Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vincenza Vinaccia"'
Autor:
Pier Paolo Piccaluga, Michele Malagola, Michela Rondoni, Mario Arpinati, Stefania Paolini, Anna Candoni, Renato Fanin, Emanuela Messa, Maria Teresa Pirrotta, Francesco Lauria, Giuseppe Visani, Daniele Alberti, Francesca Rancati, Vincenza Vinaccia, Domenico Russo, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli
Publikováno v:
Haematologica, Vol 92, Iss 12 (2007)
We evaluated safety and efficacy of imatinib (600 mg) in 36 c-KIT+ acute myeloid leukemia patients not amenable to receive conventional chemotherapy. No patient achieved complete remission. One patient obtained a hematologic improvement (platelet inc
Externí odkaz:
https://doaj.org/article/1b59a6321b3d4ea3b037843e694241c3
Publikováno v:
Airway pharmacology and treatment.
Publikováno v:
Recenti progressi in medicina. 104(10)
The physician's need for medical information updates has been studied extensively in recent years but the point of view of the pharmaceutical industry on this need has rarely been considered. This paper reports the results of a retrospective analysis
Autor:
Alexia Bertuzzi, Alessandro Comandone, Vincenza Vinaccia, Silvia Stacchiotti, Alessandro Gronchi, Silvana Pilotti, Virginia Ferraresi, Giovanni Grignani, Roger Stupp, Paolo G. Casali, Alessandra Longhi, Paola Amore, Carlo Spreafico, Antonella Messina, Elena Tamborini
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(9)
Purpose To explore the antitumor activity of imatinib in patients with advanced platelet-derived growth factor β (PDGFB)/PDGF receptor β (PDGFRB)–positive chordomas. Patients and Methods In a collaborative Italian-Swiss, prospective, phase II cli
Autor:
Alessandro Gronchi, Licia Laurino, Luigi Mariani, Carlo Capella, Angelo Sidoni, Sabrina Rossi, Luisa Toffolatti, Vincenza Vinaccia, Italo Bearzi, Aurelio Sonzogni, Guido Mazzoleni, Paolo G. Casali, Angelo Paolo Dei Tos, Gianluigi Arrigoni, Rosalba Miceli, Luca Messerini, Chiara Gnocchi
Gastrointestinal stromal tumor (GIST) natural history per se has not been extensively investigated yet, with most data being drawn from large studies with a relevant referral bias. Hence, the estimation of prognosis still remains a critical issue. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2298145619e0831ffda350991bdbb5b3
http://hdl.handle.net/11577/3243715
http://hdl.handle.net/11577/3243715
Autor:
Anna Candoni, Michele Baccarani, Emanuela Messa, Vincenza Vinaccia, Michela Rondoni, Maria Teresa Pirrotta, Stefania Paolini, Domenico Russo, Renato Fanin, Giovanni Martinelli, Michele Malagola, Giuseppe Visani, Francesca Rancati, Francesco Lauria, Daniele Alberti, Giuseppe Saglio, Pier Paolo Piccaluga, Mario Arpinati
Publikováno v:
Università degli Studi di Siena-IRIS
We evaluated safety and efficacy of imatinib (600 mg) in 36 c-KIT+ acute myeloid leukemia patients not amenable to receive conventional chemotherapy. No patient achieved complete remission. One patient obtained a hematologic improvement (platelet inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5366ab1306dde3eccb705d247a1685
http://hdl.handle.net/11390/858431
http://hdl.handle.net/11390/858431
Autor:
Roberta Rondena, Vito Lorusso, Vincenza Vinaccia, Francesco Giotta, Giacomo Cartenì, Roberto Bordonaro, Dino Amadori, Simona Scalone
Publikováno v:
The oncologist. 11(7)
Purpose. This study evaluated the efficacy and safety of zoledronic acid in breast cancer patients with newly diagnosed bone metastases. Materials and Methods. Patients diagnosed with bone metastases ≤ 6 weeks prior to first visit were enrolled. Zo
Autor:
U. De Giorgi, Elena Fumagalli, Sergio Frustaci, D. Comandini, Paolo G. Casali, Vincenza Vinaccia, Alessandro Comandone, Antonella Messina, Carlo Spreafico, M. C. Marré Brunenghi
Publikováno v:
Journal of Clinical Oncology. 22:9028-9028
9028 Background: As from the first patients treated in 2000–2001, Imatinib mesylate was shown to be highly effective in advanced GIST, but patterns of tumor response were seen to be peculiar. Methods: From March to December 2002, 135 Italian patien